At Valinor, our state-of-the-art machine learning models fast-track your drug development process by simulating therapeutic efficacy, empowering confident, data-driven decisions before costly wet-lab research and clinical trials.
Our advanced generative models accurately simulate drug efficacy across doses, patients, and clinical endpoints—saving valuable time, reducing costs, and driving better outcomes.
Identify target gene responses across differentially expressed genes
Simulate drug performance across diverse patient profiles and dose conditions
Anticipate adverse effects early in your development pipeline
Pinpoint optimal therapeutic areas based on molecular profiles
Evaluate your asset’s impact against specific clinical endpoints across therapeutic areas
From toxicity simulation to patient stratification, Valinor enables informed development decisions and accelerates therapeutic breakthroughs.
Simulate small molecule efficacy early, prioritizing high-value leads to streamline experiments and significantly reduce R&D costs.
.svg)
Analyze your drug’s performance against existing therapeutics across indications.
.svg)
Precisely identify optimal patient cohorts and biomarker panels ahead of clinical trials, enhancing patient stratification, improving therapeutic outcomes, and minimizing regulatory risk.
.svg)
Rapidly uncover new therapeutic indications for existing compounds, accelerating market entry and maximizing return on investment.
Valinor develops advanced ML models trained on proprietary patient-derived samples, capturing comprehensive multi-omic and clinical assay profiles both before and after treatment.
Get Started for Free
.svg)